Replies to post #999 on Vascular Biogenics Ltd (VBLT)

[Oren1976]

All the durable full responders in phase 1 and phase 2 rgbm were on vb111 monotherapy . Not even one complete responder in the combo with avastin. Vbl designed a bad ph3 which is not similar to the ph2. Maybe the spa forced them to do it and may Be this is why they declined spa offer in ovary. Avastin disturb vb111 and one of the proof is the fact no complete response in the combo.